EUVIMEDDécouvrir EUVIMED
MetaanalyseSystematische Übersicht

Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: A systematic review and meta‐analysis of clinical trials

Probiotika, Präbiotika und Synbiotika bei Diabetes mellitus Typ 1: systematische Übersichtsarbeit und Metaanalyse klinischer Studien

Amir Reza Moravejolahkami iD, Mehdi Shakibaei iD, Andrea Mary Fairley iD, Manoj Sharma iD

Diabetes/Metabolism Research and Reviews · 2024-02 · 40 (2)

DOI: 10.1002/dmrr.3655 ↗

Auf einen Blick

Fünf RCTs mit 356 Patient:innen untersuchten Probiotika, Präbiotika und Synbiotika bei T1DM. Nur Nüchternblutzucker sank unter Probiotika; HbA1c, C-Peptid und Insulinbedarf änderten sich nicht signifikant.

Fragestellung

Welche Effekte haben Probiotika, Präbiotika und Synbiotika auf FBG, HbA1c, C-Peptid und Insulinbedarf bei T1DM?

Methode

Systematische Suche bis Oktober 2022 in PubMed, EMBASE, Scopus, Google Scholar, ScienceDirect, Web of Science und der Central Cochrane Library; Metaanalyse mit Random-Effects-Modellen.

Ergebnisse

5 randomisierte kontrollierte Studien (n = 356; mittleres Alter 11,7 Jahre). FBG unter Probiotika: WMD −31,24 mg/dL (95 %-KI −45,65 bis −16,83; p < 0,001). Kein signifikanter Effekt auf HbA1c, C-Peptid oder Insulinbedarf.

Einschränkungen

Die Evidenz ist begrenzt; weitere Studien sind erforderlich.

Schlussfolgerung der Autor:innen

Probiotische Supplementierung könnte eine ergänzende therapeutische Strategie bei T1DM sein.

Kernaussagen

  • FBG sank unter Probiotika um 31,24 mg/dL
  • Kein signifikanter Effekt auf HbA1c, C-Peptid oder Insulinbedarf
  • Evidenzlage laut Autor:innen begrenzt

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Metaanalyse in Diabetes/Metabolism Research and Reviews, published online on 2023-05-14. Written by Amir Reza Moravejolahkami and 3 co-authors. Institution: Department of Clinical Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Sciences, Isfahan, Iran. Major MEDLINE topics: Diabetes Mellitus, Type 1, Probiotics, Synbiotics, Prebiotics. Cited 33 times so far (Crossref); 45 references.

Auf einen BlickRésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Dysbiosis or imbalance of microbes in the gut has been associated with susceptibility and progression of type 1 diabetes mellitus (T1DM). The present systematic review and meta‐analysis examined the effects of probiotics, prebiotics, and synbiotics on fasting blood glucose (FBG), haemoglobin A1c (HbA1c), C‐peptide, and insulin requirements in T1DM patients. A systematic search for trials published up to October 2022 was conducted in PubMed, EMBASE, Scopus, Google Scholar, ScienceDirect, Web of Science, and the Central Cochrane Library. Random effect models were used to synthesise quantitative data by STATA 14 . After the evaluation of 258 identified entries, five randomised controlled trials ( n = 356; mean age = 11.7 years old) were included. The pooled effect size showed that FBG decreased following probiotic supplementation (weighted mean difference = −31.24 mg/dL; 95% confidence interval = −45.65, −16.83; p < 0.001), however, there was no significant improvement in serum HbA1c, C‐peptide, and insulin requirements. Probiotic supplementation could be a complementary therapeutic strategy in T1DM. The evidence is limited; therefore, it is crucial to conduct more trials.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1ProbioticsSynbioticsPrebioticsHumansGlycated HemoglobinBlood GlucoseClinical Trials as TopicRandomized Controlled Trials as Topic

Author keywords

blood glucosediabetes mellitus, type 1glycated haemoglobin Ameta-analysisprobioticssystematic review

Substances

Prebioticshemoglobin A1c protein, humanGlycated HemoglobinBlood Glucose

Authors and institutions

  • Department of Clinical Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Faculty of Medicine, Institute of Anatomy, Musculoskeletal & Tumor Biology Research Group, Ludwig-Maximilians-University Munich, Munich, Germany.
  • School of Biomedical, Nutritional and Sport Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
  • Department of Social & Behavioral Health, School of Public Health, University of Nevada, Las Vegas, Nevada, USA.
  • Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Nevada, USA.

ORCID profiles: Amir Reza Moravejolahkami, Mehdi Shakibaei, Andrea Mary Fairley, Manoj Sharma

Cite

APA

Moravejolahkami, A. R., Shakibaei, M., Fairley, A. M., & Sharma, M. (2024). Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: A systematic review and meta‐analysis of clinical trials. Diabetes/Metabolism Research and Reviews, 40(2). https://doi.org/10.1002/dmrr.3655

Vancouver

Moravejolahkami AR, Shakibaei M, Fairley AM, Sharma M. Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: A systematic review and meta‐analysis of clinical trials. Diabetes/Metabolism Research and Reviews. 2024;40(2). doi:10.1002/dmrr.3655

BibTeX
@article{Moravejolahkami2024,
  author = {Moravejolahkami, Amir Reza and Shakibaei, Mehdi and Fairley, Andrea Mary and Sharma, Manoj},
  title = {Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: A systematic review and meta‐analysis of clinical trials},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  volume = {40},
  number = {2},
  doi = {10.1002/dmrr.3655}
}
Start for free →